Lista de obras -

Aldosterone and progression of kidney disease

artículo científico publicado en 2009

Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.

artículo científico publicado en 2010

Autotaxin Inhibitor Protects from Chronic Allograft Injury in Rat Kidney Allotransplantation

scientific article published on 24 September 2019

C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation

artículo científico publicado en 2007

Conversion from Brand-Name Neoral to the Generic Ciqorin in Stable Renal Transplant Recipients

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

artículo científico publicado en 2012

Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4.

artículo científico publicado en 2016

Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial

artículo científico publicado en 2019

Global Cardiovascular and Renal Outcomes of Reduced GFR.

artículo científico publicado en 2017

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

artículo científico publicado en 2012

Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

artículo científico publicado en 2018

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

artículo científico publicado en 2018

Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

article by Catherine Owens Johnson et al published March 2019 in Lancet Neurology

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Dise

artículo científico publicado en 2018

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition

artículo científico publicado en 2015

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

artículo científico publicado en 2018

In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development.

artículo científico publicado en 2013

Investigational drugs for diabetic nephropathy

Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration

artículo científico publicado en 2019

Limited sampling strategies for the estimation of sirolimus daily exposure in kidney transplant recipients on a calcineurin inhibitor-free regimen.

artículo científico publicado en 2009

Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy.

artículo científico publicado en 2018

Maintenance Dialysis throughout the World in Years 1990 and 2010.

artículo científico publicado en 2015

Maintenance Immunosuppression in Kidney Transplantation

Maternal and environmental risk factors for neonatal AKI and its long-term consequences

Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

artículo científico publicado en 2018

Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.

artículo científico publicado en 2013

Mesenchymal stromal cells in renal transplantation: opportunities and challenges.

artículo científico publicado en 2016

Mesenchymal stromal cells to control donor-specific memory T cells in solid organ transplantation

artículo científico publicado en 2015

Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial

artículo científico publicado en 2019

Omega-3 polyunsaturated fatty acids affect sirolimus exposure in kidney transplant recipients on calcineurin inhibitor-free regimen

artículo científico publicado en 2010

Paricalcitol for secondary hyperparathyroidism in renal transplantation

artículo científico publicado en 2014

Pharmacokinetic/pharmacodynamic drug interaction between rosiglitazone and mycophenolate mofetil in kidney transplantation: a case report

artículo científico publicado en 2008

Pharmacokinetics of mycophenolate sodium and comparison with the mofetil formulation in stable kidney transplant recipients

artículo científico publicado en 2007

Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

artículo científico publicado en 2018

Progression, Remission and Regression of Chronic Renal Diseases

artículo científico publicado en 2016

Recent advances in immunosuppression and acquired immune tolerance in renal transplants

artículo científico publicado en 2016

Renal Graft Function and Low-Dose Cyclosporine Affect Mycophenolic Acid Pharmacokinetics in Kidney Transplantation ⬇️

artículo científico publicado el 15 de septiembre de 2011

Should We Still Believe in Randomized Controlled Trials in Nephrology?

article by Monica Cortinovis et al published 20 September 2016 in Nephron

Sirolimus therapy to halt the progression of ADPKD.

artículo científico publicado en 2010

[Renal transplantation in Autosomal Dominant Polycystic Kidney Disease (ADPKD)].

artículo científico publicado en 2016

[Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Somatostatin analogues and mTOR inhibitors].

artículo científico publicado en 2016

Lista de obras de

Aldosterone and progression of kidney disease

Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.

Autotaxin Inhibitor Protects from Chronic Allograft Injury in Rat Kidney Allotransplantation

C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation

Conversion from Brand-Name Neoral to the Generic Ciqorin in Stable Renal Transplant Recipients

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4.

Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial

Global Cardiovascular and Renal Outcomes of Reduced GFR.

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Dise

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development.

Investigational drugs for diabetic nephropathy

Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration

Limited sampling strategies for the estimation of sirolimus daily exposure in kidney transplant recipients on a calcineurin inhibitor-free regimen.

Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy.

Maintenance Dialysis throughout the World in Years 1990 and 2010.

Maintenance Immunosuppression in Kidney Transplantation

Maternal and environmental risk factors for neonatal AKI and its long-term consequences

Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.

Mesenchymal stromal cells in renal transplantation: opportunities and challenges.

Mesenchymal stromal cells to control donor-specific memory T cells in solid organ transplantation

Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial

Omega-3 polyunsaturated fatty acids affect sirolimus exposure in kidney transplant recipients on calcineurin inhibitor-free regimen

Paricalcitol for secondary hyperparathyroidism in renal transplantation

Pharmacokinetic/pharmacodynamic drug interaction between rosiglitazone and mycophenolate mofetil in kidney transplantation: a case report

Pharmacokinetics of mycophenolate sodium and comparison with the mofetil formulation in stable kidney transplant recipients

Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

Progression, Remission and Regression of Chronic Renal Diseases

Recent advances in immunosuppression and acquired immune tolerance in renal transplants

Renal Graft Function and Low-Dose Cyclosporine Affect Mycophenolic Acid Pharmacokinetics in Kidney Transplantation ⬇️

Should We Still Believe in Randomized Controlled Trials in Nephrology?

Sirolimus therapy to halt the progression of ADPKD.

[Renal transplantation in Autosomal Dominant Polycystic Kidney Disease (ADPKD)].

[Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Somatostatin analogues and mTOR inhibitors].